Literature DB >> 10924615

Secretor genotyping for A385T, G428A, C571T, C628T, 685delTGG, G849A, and other mutations from a single PCR.

L Svensson1, A Petersson, S M Henry.   

Abstract

BACKGROUND: The secretor status of an individual is important for disease relationship studies, because it determines the presence of ABH blood group antigens in the gastrointestinal tract and bodily secretions. Routine serologic methods for determining secretor status are unreliable. Current strategies based on PCR for genotyping require relatively large amounts of DNA and have to be done as several separate experiments. STUDY DESIGN AND METHODS: A single, multiplex PCR technique followed by RFLP digestion with four restriction enzymes produced unique genotype profiles for most known secretor (FUT2) mutations.
RESULTS: Samples from a range of individuals with common and rare secretor genotypes were analyzed. Each gave unique patterns that allowed secretor genotypes to be determined.
CONCLUSION: By using the method described here and genomic DNA, a secretor genotype based on the FUT2 mutations A385T, G428A, C571T, C628T, 685delTGG, and G849A could be accurately determined.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10924615     DOI: 10.1046/j.1537-2995.2000.40070856.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  11 in total

1.  Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium.

Authors:  Brian M Wolpin; Peter Kraft; Mousheng Xu; Emily Steplowski; Martin L Olsson; Alan A Arslan; H Bas Bueno-de-Mesquita; Myron Gross; Kathy Helzlsouer; Eric J Jacobs; Andrea LaCroix; Gloria Petersen; Rachael Z Stolzenberg-Solomon; Wei Zheng; Demetrius Albanes; Naomi E Allen; Laufey Amundadottir; Melissa A Austin; Marie-Christine Boutron-Ruault; Julie E Buring; Federico Canzian; Stephen J Chanock; J Michael Gaziano; Edward L Giovannucci; Göran Hallmans; Susan E Hankinson; Robert N Hoover; David J Hunter; Amy Hutchinson; Kevin B Jacobs; Charles Kooperberg; Julie B Mendelsohn; Dominique S Michaud; Kim Overvad; Alpa V Patel; Maria-José Sanchéz; Leah Sansbury; Xiao-Ou Shu; Nadia Slimani; Geoffrey S Tobias; Dimitrios Trichopoulos; Paolo Vineis; Kala Visvanathan; Jarmo Virtamo; Jean Wactawski-Wende; Joanne Watters; Kai Yu; Anne Zeleniuch-Jacquotte; Patricia Hartge; Charles S Fuchs
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-10-22       Impact factor: 4.254

Review 2.  Breaking the Glyco-Code of HIV Persistence and Immunopathogenesis.

Authors:  Florent Colomb; Leila B Giron; Irena Trbojevic-Akmacic; Gordan Lauc; Mohamed Abdel-Mohsen
Journal:  Curr HIV/AIDS Rep       Date:  2019-04       Impact factor: 5.071

3.  Hematopoietic Chimera in a Male Blood Donor and His Dizygotic Twin Sister.

Authors:  Marcos P Miola; Alessandro G Lopes; Alessandra P Silva; Edney G C Gomes; Leticia A F Machado; Wanessa A Veloso; Carlos A Costa; Roberta M Fachini; Octávio Ricci Junior; Cinara C Brandão de Mattos; Luiz Carlos de Mattos
Journal:  Transfus Med Hemother       Date:  2019-02-27       Impact factor: 3.747

Review 4.  Epithelial glycosylation in gut homeostasis and inflammation.

Authors:  Yoshiyuki Goto; Satoshi Uematsu; Hiroshi Kiyono
Journal:  Nat Immunol       Date:  2016-10-19       Impact factor: 25.606

5.  Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci.

Authors:  Trine Folseraas; Espen Melum; Philipp Rausch; Brian D Juran; Eva Ellinghaus; Alexey Shiryaev; Jon K Laerdahl; David Ellinghaus; Christoph Schramm; Tobias J Weismüller; Daniel Nils Gotthardt; Johannes Roksund Hov; Ole Petter Clausen; Rinse K Weersma; Marcel Janse; Kirsten Muri Boberg; Einar Björnsson; Hanns-Ulrich Marschall; Isabelle Cleynen; Philip Rosenstiel; Kristian Holm; Andreas Teufel; Christian Rust; Christian Gieger; H-Erich Wichmann; Annika Bergquist; Euijung Ryu; Cyriel Y Ponsioen; Heiko Runz; Martina Sterneck; Severine Vermeire; Ulrich Beuers; Cisca Wijmenga; Erik Schrumpf; Michael P Manns; Konstantinos N Lazaridis; Stefan Schreiber; John F Baines; Andre Franke; Tom H Karlsen
Journal:  J Hepatol       Date:  2012-04-18       Impact factor: 25.083

6.  Intestinal Norovirus Binding Patterns in Nonsecretor Individuals.

Authors:  Georges Tarris; Marie Estienney; Philippe Daval-Frérot; Anne-Cécile Lariotte; Damien Aubignat; Karine Sé; Christophe Michiels; Laurent Martin; Alexis de Rougemont; Gaël Belliot
Journal:  J Virol       Date:  2022-09-19       Impact factor: 6.549

7.  Human Intestinal Enteroids: a New Model To Study Human Rotavirus Infection, Host Restriction, and Pathophysiology.

Authors:  Kapil Saxena; Sarah E Blutt; Khalil Ettayebi; Xi-Lei Zeng; James R Broughman; Sue E Crawford; Umesh C Karandikar; Narayan P Sastri; Margaret E Conner; Antone R Opekun; David Y Graham; Waqar Qureshi; Vadim Sherman; Jennifer Foulke-Abel; Julie In; Olga Kovbasnjuk; Nicholas C Zachos; Mark Donowitz; Mary K Estes
Journal:  J Virol       Date:  2015-10-07       Impact factor: 5.103

Review 8.  Fucosyltransferase 2: a genetic risk factor for primary sclerosing cholangitis and Crohn's disease--a comprehensive review.

Authors:  Luca Maroni; Stan F J van de Graaf; Simon D Hohenester; Ronald P J Oude Elferink; Ulrich Beuers
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

9.  Hypertonic saline solutions do not influence the solubility of sputum from secretor and non-secretor cystic fibrosis patients.

Authors:  Marcelo A I Barboza; Cinara C Brandão de Mattos; Ana Iara C Ferreira; Paulo R Barja; Newton Santos de Faria Junior; Luís Vicente F de Oliveira; Luiz C de Mattos
Journal:  Arch Med Sci       Date:  2011-05-17       Impact factor: 3.318

10.  Histo-blood group gene polymorphisms as potential genetic modifiers of infection and cystic fibrosis lung disease severity.

Authors:  Jennifer L Taylor-Cousar; Maimoona A Zariwala; Lauranell H Burch; Rhonda G Pace; Mitchell L Drumm; Hollin Calloway; Haiying Fan; Brent W Weston; Fred A Wright; Michael R Knowles
Journal:  PLoS One       Date:  2009-01-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.